Seres Therapeutics, Inc. (MCRB): 8-K filed Jul 8, 2026

Form type

8-K

Filing date

Jul 8, 2026

Accession number

0001193125-26-298525

Filer

Seres Therapeutics, Inc. (CIK 1609809)